Sung Sun-sang J
Division of Rheumatology, University of Virginia Health Sciences Center, Charlottesville, VA.
Methods Mol Med. 2008;138:97-106. doi: 10.1007/978-1-59745-366-0_9.
Dendritic cells (DC) are widely considered to be the major antigen-presenting cell (APC) type in immune responses. These cells are obtained from adherent cells or are purified CD14(+) monocytes from peripheral blood mononuclear cells (PBMC) by in vitro stimulation with granulocyte, macrophage-colony-stimulating factor (GM-CSF) plus interleukin (IL)-4. They express high levels of MHC class II and costimulatory molecules, internalize Ag rapidly via Fc receptors and mannose receptors, and, by macropinocytosis, produce large amounts of IL-12 on CD40 ligation, and are potent in presenting soluble Ag and in stimulating allogeneic mixed-leukocyte reactions. To study primary T-cell responses and cytokine production in allergy patients, we have developed an in vitro system by using highly purified T cells as responder cells and monocyte-derived DC (MDC) as the APC. MDC provide a convenient and potent APC source for T-cell response studies.
树突状细胞(DC)被广泛认为是免疫反应中主要的抗原呈递细胞(APC)类型。这些细胞可从贴壁细胞获得,或通过用粒细胞、巨噬细胞集落刺激因子(GM-CSF)加白细胞介素(IL)-4进行体外刺激,从外周血单核细胞(PBMC)中纯化出CD14(+)单核细胞而获得。它们高水平表达MHC II类分子和共刺激分子,通过Fc受体和甘露糖受体快速内化抗原,并通过巨吞饮作用在CD40连接时产生大量IL-12,在呈递可溶性抗原和刺激同种异体混合淋巴细胞反应方面很有效。为了研究过敏患者的原发性T细胞反应和细胞因子产生,我们通过使用高度纯化的T细胞作为反应细胞和单核细胞衍生的DC(MDC)作为APC,开发了一种体外系统。MDC为T细胞反应研究提供了一种方便且有效的APC来源。